Dominican Republic Country Profile

Dominican Republic country flag

Dominican Republic Country Profile

Discover more about CDC’s work in Dominican Republic by viewing our detailed country profile

Country Overview

CDC works with the Government of the Dominican Republic in the fight against HIV and tuberculosis (TB) to increase detection, treatment, and retention in care of people living with HIV (PLHIV). The goal of this partnership is to achieve HIV and TB epidemic control; improve the quality of treatment for both diseases; and increase access to, and uptake of HIV testing, counseling, and other evidence-based interventions among key populations– including men who have sex with men, people who inject drugs, and sex workers–who are at greater risk for HIV infection. CDC also supports the Ministry of Health to strengthen its disease surveillance systems, including a national electronic surveillance system for reportable diseases; an electronic TB reporting system; and a monitoring system for patients receiving treatment for HIV.

Per Capita GNI



Population (million)



Under 5 Mortality

33.8/1,000 Live Births


Life Expectancy

74.3 Years


Estimated HIV Prevalence


(Ages 15-49): (2021)

Estimated AIDS Deaths


(Age≥15) (2021)

TB Treatment Success Rate



Estimated TB Incidence



Estimated Orphans Due to AIDS



TB patients with known HIV-status who are HIV-positive



Reported Number Receiving Antiretroviral Therapy (ART)


(Age≥15) (2021)

Strategic Focus

Centers for Disease Control and Prevention – Dominican Republic (CDC/DR) through the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) has three main goals related to HIV and Tuberculosis (TB):

1) Increase detection, treatment, and retention of people living with HIV (PLHIV) to reduce mortality and HIV transmission and reach UNAIDS 95-95-95 targets to obtain epidemic control.
2) Improve the quality of HIV and TB care, and
3) Increase access to, and uptake of, HIV testing and counseling (HTC) and other evidence-based interventions among key and priority populations (KP/PP)

Key strategies include:
1) Supporting the Government of the DR (GoDR) in the transition to Test and Start for antiretroviral treatment (ART) initiation
2) Implementing service delivery models that contribute to closing the treatment gap for KP/PP, and
3) Addressing system-wide challenges in the national HIV response, such as viral load (VL) monitoring, supply chain management, health information management and workforce capacity development

PEPFAR’s cornerstone approaches in the DR include:
1) Strategically pairing local Non-Governmental Organizations (NGO) with public sector health facilities, to foster exchanges that lead to better service quality and performance in both sectors
2) Implementing different HTC modalities, including facility- and community-based index client testing, and
3) Developing differentiated models of HIV treatment, notably through mobile clinics, to ensure that migrants and other hard-to-reach populations receive comprehensive treatment in a non-stigmatizing environment

Key Activities and Accomplishments

CDC/DR implements PEPFAR activities by working directly with the Ministry of Health (MoH) to foster system-wide changes, and supporting clinic-level activities currently focused on 9 facilities and 2 mobile clinics in 4 high-HIV-burden provinces.

Epidemiology and Surveillance: CDC/DR supports the MoH to characterize its HIV/AIDS epidemic by assisting in the development and implementation of the National HIV Patient Monitoring System (HPMS), which collects key information to describe HIV risk factors, characterize key populations, and assess the HIV cascade; and the HIV Testing Monitoring System (HTMS), which is the first nominal HIV testing registry implemented in the country.

Laboratory Systems: CDC/DR works to scale up viral load (VL) testing in all patients on ART and strengthen the quality of laboratory services to provide accurate and reliable CD4 count and VL testing. Through technical guidance and training, CDC/DR supports the MoH in complying with International Health Regulations by increasing laboratory capacity to perform molecular and genetic testing, establishing a robust public health laboratory network, and further improving the laboratory’s role in disease surveillance.

Tuberculosis: CDC/DR provides technical assistance in three primary areas: 1) strengthening infection control practices in HIV clinics; 2) ensuring clinics accurately collect and report TB and TB-HIV co-infection data; and 3) building surveillance and epidemiologic capacity through the National TB Patient Monitoring System.

CDC/DR Accomplishments include:

• Established the country’s first 2 mobile clinics in Santiago and Puerto Plata
• Developed an electronic HIV Patient Monitoring System (HPMS/FAPPS) to track individuals on ART
• Implemented the Test and Start strategy at the 11 sites CDC/DR supports
• Piloted a biometric patient tracking system to follow patients on ART across HIV care sites
• Developed and implementing a nominal electronic HIV testing register (SIREN-P)
• Implemented the first pilot project to offer pre-exposure prophylaxis (PrEP) to men who have sex with men (MSM) in the DR
• Implemented TB infection control plans at 11 sites
• Trained >200 field epidemiologists at the basic and intermediate levels

social media card. photo of a boy

Social Media Card

CDC’s innovative efforts to Find, Cure, and Prevent TB are creating a safer America and a safer world.

social media card. photo, boy looking up

Social Media Card

CDC study provides new evidence that Drug-Resistant Tuberculosis is set to rise in some of the world’s highest burden countries and suggests that it will increasingly be transmitted from Person to Person

social media card. photo, healthcare worker and patient

Social Media Card

TB is the #1 killer of people living with HIV. TB preventative treatment protects those with HIV from contracting TB Disease. It’s effective, It’s affordable. It saves lives.

Page last reviewed: September 30, 2021, 12:00 AM